Literature DB >> 1149188

Control of aldosterone secretion in the spontaneously hypertensive rat.

R H Freeman, J O Davis, N V Aharon, S Ulick, M H Weinberger.   

Abstract

Adrenal secretion rates of aldosterone, corticosterone, and deoxycorticosterone were studied sequentially in the spontaneously hypertensive rat and the normotensive Kyoto Wistar rat. Steroid secretion was studied at three different ages: 7-8, 11-13, and 22-25 weeks. Also, peripheral plasma levels of aldosterone and plasma renin activity were determined in both the spontaneously hypertensive and the normotensive rats at 7-8 weeks of age. Aldosterone secretion was elevated markedly in dexamethasone-morphine-treated spontaneously hypertensive rats at both 7-8 and 11-13 weeks of age but was not significantly different from control in 22-25-week-old spontaneously hypertensive rats. No statistically significant differences in corticosterone or deoxycorticosterone secretion rates were observed between the spontaneously hypertensive rats and the normotensive Kyoto Wistar controls; however, the data suggested that dexamethasone did not suppress adrenocorticotropic hormone in the 7-8- and 11-13-week-old spontaneously hypertensive rats to the same extent that it did in the normotensive Kyoto Wistar rats. Therefore, aldosterone secretion was reexamined in acutely hypophysectomized 7-8-week-old rats to eliminate completely the influence of the anterior pituitary; no differences in aldosterone, corticosterone, or deoxycorticosterone secretion rates were observed between hypophysectomized spontaneously hypertensive rats and normotensive Kyoto Wistar rats. Moreover, aldosterone secretion in the hypophysectomized 7-8-week-old spontaneously hypertensive rats was reduced markedly compared with that in the intact 7-8-week old spontaneously hypertensive rats, thus confirming the importance of the pituitary in these animals. Determinations of peripheral plasma aldosterone concentration and plasma renin activity in unstressed 7-8-week-old spontaneously hypertensive and normotensive rats revealed that both parameters were depressed significantly in the spontaneously hypertensive rats. Thus, the present data indicate that the renin-angiotensin-aldosterone system is suppressed in the spontaneously hypertensive rat but do not suggest that the system is critically involved in the hypertensive process in these animals

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1149188     DOI: 10.1161/01.res.37.1.66

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

1.  Zona reticularis in aging spontaneously hypertensive rats: a quantitative ultrastructural study of 70- and 95-week-old animals.

Authors:  P A Nickerson; L G Feld; J B VanLiew
Journal:  Am J Pathol       Date:  1979-11       Impact factor: 4.307

2.  Markedly elevated specific renin levels in the adrenal in genetically hypertensive rats.

Authors:  M Naruse; T Inagami
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

3.  The adrenal cortex in spontaneously hypertensive rats. A quantitative ultrastructural study.

Authors:  P A Nickerson
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

4.  Transplantation of pituitary and adrenal glands of spontaneously hypertensive rats into hypophysectomized or adrenalectomized, normotensive Sprague-Dawley rats.

Authors:  B C Wexler
Journal:  Br J Exp Pathol       Date:  1980-08

5.  Decreased adrenal responsiveness to angiotensin II: a defect present in spontaneously hypertensive rats. A possible model of human essential hypertension.

Authors:  G H Williams; L M Braley; A Menachery
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

6.  Impact of sex and pathophysiology on optimal drug choice in hypertensive rats: quantitative insights for precision medicine.

Authors:  Sameed Ahmed; Jennifer C Sullivan; Anita T Layton
Journal:  iScience       Date:  2021-03-20

7.  Wnt/β-catenin signaling in the adrenal glands of rats in various types of experimental hypertension.

Authors:  Irena Kasacka; Żaneta Piotrowska; Natalia Domian; Alicja Lewandowska
Journal:  Endocr Connect       Date:  2022-07-19       Impact factor: 3.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.